Free water changes and their correlations with multimodal biomarkers in frontotemporal dementia
Study Overview The investigation into the role of free water changes in frontotemporal dementia (FTD) explores how these fluctuations correlate […]
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial
Study Overview The trial investigated the efficacy and safety of an oral formulation of deucrictibant for treating acute episodes of
Traumatic brain injury in China: an update on epidemiology, care pathways, and clinical research
Epidemiology of Traumatic Brain Injury in China Traumatic brain injury (TBI) represents a significant public health issue in China, where
Pediatric-Onset Multiple Sclerosis Presenting With Persistent Vertigo, Ataxia, and Optic Nerve Atrophy in a 15-Year-Old Girl: A Case Report
Background and Context Multiple sclerosis (MS) is a chronic autoimmune disease that predominantly affects the central nervous system (CNS), characterized
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Case Studies and Observations Recent inquiries into the utilization of the endocannabinoid system for managing residual disease in relapse-free multiple
Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium-Glucose Cotransporter 2 Inhibitors
Study Overview The research investigates the discontinuation rates of Angiotensin Converting Enzyme (ACE) inhibitors among Medicare beneficiaries who are concurrently
Pediatric-Onset Multiple Sclerosis Presenting With Persistent Vertigo, Ataxia, and Optic Nerve Atrophy in a 15-Year-Old Girl: A Case Report
Study Overview The case report highlights an unusual presentation of pediatric-onset multiple sclerosis (POMS) in a 15-year-old female patient who
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Endocannabinoid System and Multiple Sclerosis The endocannabinoid system (ECS) consists of a network of receptors, endogenous cannabinoids, and metabolic enzymes
Pediatric-Onset Multiple Sclerosis Presenting With Persistent Vertigo, Ataxia, and Optic Nerve Atrophy in a 15-Year-Old Girl: A Case Report
Case Presentation A 15-year-old female patient was referred to our facility with a series of troubling neurological symptoms that had
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Endocannabinoid System Mechanisms The endocannabinoid system (ECS) plays a pivotal role in maintaining homeostasis within the body and has garnered